Literature DB >> 1711702

In vivo neurochemical effects of electroconvulsive shock studied by microdialysis in the rat striatum.

A P Zis1, G G Nomikos, G Damsma, H C Fibiger.   

Abstract

The present study examined the effects of electroconvulsive shock (ECS) on interstitial concentrations of dopamine (DA), its metabolites DOPAC and HVA and the serotonin metabolite 5-HIAA in the striatum of freely moving rats using on-line microdialysis. DA increased sharply following a single ECS. Interstitial concentrations of DOPAC. HVA and 5-HIAA also increased significantly. The ECS-induced increase in DA varied as a function of days following implantation of the microdialysis probe, being 1300%, 305% and 300% of baseline 24, 48 and 72 h after surgery, respectively. In contrast, the response of the metabolites to ECS did not differ across days following surgery, being approximately 130%, 140% and 110% of baseline for DOPAC, HVA and 5-HIAA, respectively. Seizure activity induced by the convulsant agent flurothyl did not influence dialysate DA concentrations, suggesting that the ECS-induced DA release was related to the passage of current and not to the seizure activity. Interstitial concentrations of acetylcholine and choline in the striatum increased by approximately 20% and 140%, respectively, in response to a single ECS. The DA (but not the DOPAC or HVA) response to ECS was refractory to a second ECS delivered 2 h after the first. A second ECS delivered 24 h after the first produced the normal increase in DA. The ECS-induced increase in DA was attenuated following repeated ECS (eight treatments, one every second day). Baseline DOPAC and HVA concentrations were significantly elevated by repeated ECS.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1711702     DOI: 10.1007/bf02244288

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  17 in total

1.  ECT and Parkinson's disease revisited: a "naturalistic" study.

Authors:  R Douyon; M Serby; B Klutchko; J Rotrosen
Journal:  Am J Psychiatry       Date:  1989-11       Impact factor: 18.112

2.  Chronic electroconvulsive shock increases D-1 receptor binding in rat substantia nigra.

Authors:  L J Fochtmann; R Cruciani; M Aiso; W Z Potter
Journal:  Eur J Pharmacol       Date:  1989-08-22       Impact factor: 4.432

3.  A double-blind evaluation of electroconvulsive therapy in Parkinson's disease with "on-off" phenomena.

Authors:  K Andersen; J Balldin; C G Gottfries; A K Granérus; K Modigh; L Svennerholm; A Wallin
Journal:  Acta Neurol Scand       Date:  1987-09       Impact factor: 3.209

4.  Measurement of acetylcholine release in freely moving rats by means of automated intracerebral dialysis.

Authors:  G Damsma; B H Westerink; J B de Vries; C J Van den Berg; A S Horn
Journal:  J Neurochem       Date:  1987-05       Impact factor: 5.372

5.  ECT for Parkinson's disease.

Authors:  R Abrams
Journal:  Am J Psychiatry       Date:  1989-11       Impact factor: 18.112

6.  The neuropharmacological effects of electroconvulsive shock and their relationship to the therapeutic effect of electroconvulsive therapy in depression.

Authors:  D G Grahame-Smith
Journal:  Adv Biochem Psychopharmacol       Date:  1984

7.  Lack of tolerance to nicotine-induced dopamine release in the nucleus accumbens.

Authors:  G Damsma; J Day; H C Fibiger
Journal:  Eur J Pharmacol       Date:  1989-09-22       Impact factor: 4.432

8.  Electroconvulsive shock produces large increases in interstitial concentrations of dopamine in the rat striatum: an in vivo microdialysis study.

Authors:  G G Nomikos; A P Zis; G Damsma; H C Fibiger
Journal:  Neuropsychopharmacology       Date:  1991-01       Impact factor: 7.853

9.  Chronic use of intracerebral dialysis for the in vivo measurement of 3,4-dihydroxyphenylethylamine and its metabolite 3,4-dihydroxyphenylacetic acid.

Authors:  B H Westerink; M H Tuinte
Journal:  J Neurochem       Date:  1986-01       Impact factor: 5.372

10.  Characterization of in vivo dopamine release as determined by brain microdialysis after acute and subchronic implantations: methodological aspects.

Authors:  B H Westerink; J B De Vries
Journal:  J Neurochem       Date:  1988-09       Impact factor: 5.372

View more
  12 in total

1.  The effect of intrastriatal application of directly and indirectly acting dopamine agonists and antagonists on the in vivo release of acetylcholine measured by brain microdialysis. The importance of the post-surgery interval.

Authors:  P De Boer; G Damsma; Q Schram; J C Stoof; J Zaagsma; B H Westerink
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-02       Impact factor: 3.000

2.  Transcranial magnetic stimulation induces alterations in brain monoamines.

Authors:  D Ben-Shachar; R H Belmaker; N Grisaru; E Klein
Journal:  J Neural Transm (Vienna)       Date:  1997       Impact factor: 3.575

3.  Effects of chronic electroconvulsive shock on interstitial concentrations of dopamine in the nucleus accumbens.

Authors:  G G Nomikos; A P Zis; G Damsma; H C Fibiger
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

4.  Elevated dopamine D1 receptor availability in striatum of Göttingen minipigs after electroconvulsive therapy.

Authors:  Anne M Landau; Aage Ko Alstrup; Helene Audrain; Steen Jakobsen; Mette Simonsen; Arne Møller; Poul Videbech; Gregers Wegener; Albert Gjedde; Doris J Doudet
Journal:  J Cereb Blood Flow Metab       Date:  2017-05-16       Impact factor: 6.200

5.  Chronic electroconvulsive shock and 5-HT autoreceptor activity in rat brain: an in vivo microdialysis study.

Authors:  E Gur; B Lerer; M E Newman
Journal:  J Neural Transm (Vienna)       Date:  1997       Impact factor: 3.575

6.  Rapid and lasting enhancement of dopaminergic modulation at the hippocampal mossy fiber synapse by electroconvulsive treatment.

Authors:  Katsunori Kobayashi; Yuki Imoto; Fumi Yamamoto; Mayu Kawasaki; Miyuki Ueno; Eri Segi-Nishida; Hidenori Suzuki
Journal:  J Neurophysiol       Date:  2016-10-26       Impact factor: 2.714

7.  The 5-HT1A receptor antagonist (S)-UH-301 decreases dopamine release in the rat nucleus accumbens and striatum.

Authors:  G G Nomikos; L Arborelius; B B Höök; U Hacksell; T H Svensson
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

8.  In vivo release of dopamine from rat striatum, substantia nigra and prefrontal cortex: differential modulation by baclofen.

Authors:  M Santiago; A Machado; J Cano
Journal:  Br J Pharmacol       Date:  1993-07       Impact factor: 8.739

9.  Effects of acute and chronic electroconvulsive shock on noradrenaline release in the rat hippocampus and frontal cortex.

Authors:  D N Thomas; D J Nutt; R B Holman
Journal:  Br J Pharmacol       Date:  1992-06       Impact factor: 8.739

10.  Effects of chronic antidepressant treatment on dopamine-related [3H]SCH 23390 and [3H]spiperone binding in the rat striatum.

Authors:  P R Paetsch; A J Greenshaw
Journal:  Cell Mol Neurobiol       Date:  1992-12       Impact factor: 5.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.